Annual Clinical Contract Evaluations: Are You Ready?

By AHRMM

AHRMM Webinar Image

 

Price: Member: FREE  |  Non-Member: $99.00

CEC Hours: 1

Order Webinar

 

Description:

The process of annual clinical contract evaluations can be time consuming and overwhelming, and supply chain has a unique opportunity to support the continuum of care as we expand our CQO efforts and strive to meet requirements. In this webinar, we discuss the clinical contract evaluation process, including government requirements, expectations, and improving contract performance with the use of key performance indicators.

Attendees will hear firsthand what the Dana-Farber Cancer Institute (DFCI) learned during their last Joint Commission inspection regarding the evaluation process and the effectiveness of their contracts. In addition, DFCI will share how their annual clinical contract evaluation process has matured through the improvement of existing contract management technology and the automation of the evaluation process.

 

Learning Objectives:
  • Characterize a clinical contract.
  • Explain the annual clinical contract evaluation requirements.
  • Define key performance indicators.

 

Presenters:
  • Sarah Buck — Supply Chain Business Analyst, Dana-Farber Cancer Institute
  • Susan Wills — Director Strategic Sourcing and Contracts, Dana-Farber Cancer Institute

 

Related Resources

Webcast
In the third part of the the FDA Unique Device Identification (UDI) “Unit of Use” (UOU) webcast series, we cover several potential use cases for th
Webcast
In part two of the FDA Unique Device Identification (UDI) Unit of Use (UOU) webcast series, we cover the FDA definition of the term, Unit of Use.
Supply Chain Strategies & Solutions Article
By: Mike Berger
Supply Chain Strategies & Solutions Article
From a supply chain perspective, the use of UDIs will help with the visibility of supplies throughout the continuum of care.
Case Studies
WORK GROUP TITLE: UDI Capture Work Group CASE STUDY PARTICIPANTS:
Case Studies
WORK GROUP TITLE: UDI Capture Work Group CASE STUDY PARTICIPANTS: